Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROSIGLITAZONE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

42.8%
Female
57.2%
Male

Age Information

The average age of patients reporting adverse events with ROSIGLITAZONE is 60.2 years.

Geographic Distribution

The majority of adverse event reports for ROSIGLITAZONE originate from COUNTRY NOT SPECIFIED.

Report Summary & Outcomes

45,976
Total Reports
45,976
As Primary/Secondary Suspect
4,661
Deaths Reported
23,675
Hospitalizations
29
Life-Threatening
30
Disabilities

Reporting Timeline

First adverse event report: 1978. Most recent report: 20250428. View full timeline →

More About ROSIGLITAZONE

ROSIGLITAZONE Full Profile Reports by Year Drug Interactions